Doctor profile · Federal record
Dr. Lance Scott, M.D.
Ophthalmology Physician (CMS: Ophthalmology) · Oklahoma City, OK
- NPI 1417958059
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 30 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
Operates at 4 locations .
- Primary practice
-
9821 S May Ave Ste C
Oklahoma City, OK 731597042
(405) 691-0505
fax (405) 691-0507 - Additional location
-
2408 N Commerce St
Ardmore, OK 734011356 - Additional location
-
3311 W Rock Creek RD Ste 120
Norman, OK 730722455 - Additional location
-
3366 Nw Expressway Ste 670
Oklahoma City, OK 731124416 - Mailing address
-
3037 Nw 63Rd St Ste W251
Oklahoma City, OK 731163637
Show 1 more location
Credentials & registration
- NPI registered
- August 2005 — 21 yrs on file
- Profile last updated
- December 8, 2025
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State license (1)
- Oklahoma #27666
- Medicaid
- OK #200315040A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1417958059. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
70,252
Distinct HCPCS
10
Medicare allowed
$4,727,401
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 55,020 | 202 | $37 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 3,827 | 166 | $228 | |
92134 |
Imaging of retina | 3,543 | 1,383 | $37 | |
67028 |
Injection of drug into eye | 2,432 | 514 | $110 | |
92014 |
Established patient complete exam of visual system | 2,284 | 1,212 | $116 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 774 | 51 | $273 | |
J0178 |
Injection, aflibercept, 1 mg | 584 | 92 | $854 | |
J2781 |
Injection, pegcetacoplan, intravitreal, 1 mg | 375 | 14 | $151 | |
92004 |
New patient complete exam of visual system | 362 | 362 | $139 | |
Q5124 |
Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 315 | 28 | $201 |
In context: peer comparison
Among 24 peers in this city , average services per provider: 424. This provider delivers 166× the peer median.Open Payments
Industry payments received
All-time total
$1,090
Transactions
28
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Biogen, Inc. | 12 | $548.95 | |
| Sandoz Inc. | 7 | $156.07 | |
| Apellis Pharmaceuticals, Inc. | 2 | $154.47 | |
| Genentech USA, Inc. | 3 | $83.89 | |
| Alimera Sciences, Inc. | 1 | $67.66 | |
| Coherus Biosciences Inc. | 1 | $33.67 | |
| ANI Pharmaceuticals, Inc. | 1 | $24.24 | |
| ABBVIE INC. | 1 | $20.73 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
707
Patients
279
Total drug cost
$46,620
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Latanoprost | Generic | 210 | 53 | $4,305 |
| Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha) | Brand | 112 | 70 | $1,624 |
| Prednisolone Acetate | Generic | 98 | 57 | $4,778 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 85 | 29 | $2,978 |
| Timolol Maleate | Generic | 61 | 23 | $2,308 |
| Erythromycin (Erythromycin Base) | Brand | 42 | 34 | $535 |
| Restasis (Cyclosporine) | Brand | 29 | 0 | $15,576 |
| Brimonidine Tartrate | Generic | 26 | 13 | $3,004 |
| Combigan (Brimonidine Tartrate/Timolol) | Brand | 25 | 0 | $5,800 |
| Lumigan (Bimatoprost) | Brand | 19 | 0 | $5,712 |
Hospital affiliations
Frequently asked questions
What is Dr. Lance Scott's medical specialty?
Dr. Lance Scott practices Ophthalmology Physician in Oklahoma City, OK.
Where does Dr. Lance Scott practice?
Dr. Lance Scott practices at 9821 S May Ave Ste C, Oklahoma City, OK 731597042. Office phone: 4056910505.
What is Dr. Lance Scott's NPI?
Dr. Lance Scott's National Provider Identifier (NPI) is 1417958059, issued by NPPES.
Does Dr. Lance Scott accept Medicare assignment?
Yes. Dr. Lance Scott accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lance Scott commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Injection, ranibizumab, 0.1 mg (HCPCS J2778); Imaging of retina (HCPCS 92134). Source: CMS Medicare Physician & Other Practitioners file.